Oxygenta Pharmaceutical reports standalone net loss of Rs 3.93 crore in the December 2024 quarter
Sales rise 262.95% to Rs 33.21 crore
Net Loss of Oxygenta Pharmaceutical reported to Rs 3.93 crore in the quarter ended December 2024 as against net loss of Rs 3.78 crore during the previous quarter ended December 2023. Sales rose 262.95% to Rs 33.21 crore in the quarter ended December 2024 as against Rs 9.15 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales33.219.15 263 OPM %-13.10-27.10 -PBDT-4.25-2.81 -51 PBT-4.96-3.50 -42 NP-3.93-3.78 -4Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 15 2025 | 7:32 AM IST